Boardroom Alpha
Boardroom Alpha
CON · Current Report (Form 8-K) · Filed April 30, 2026

Concentra Group Holdings Parent Inc — Current Report (Form 8-K)

Form
8-K
Filed
April 30, 2026
Period
Apr 30, 2026
Ticker
CON
Accession
0001104659-26-052886
Boardroom Alpha · Filing insights

Stockholders elected three Class II directors, approved the NEO compensation advisory vote, and ratified PricewaterhouseCoopers LLP as auditor.

About Concentra Group Holdings Parent Inc
Market cap
$3.2B
1Y TSR
+17.5%
Board grade
B-
Sector
Healthcare
CEO
William K. Newton

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): April 30, 2026

 

CONCENTRA GROUP HOLDINGS PARENT, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

001-42188

(Commission File Number)

 

Delaware 30-1006613
(State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.)

 

5080 Spectrum Drive, Suite 1200W

Addison, TX, 75001

(Address of principal executive offices) (Zip code)

 

(972) 364-8000

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class  

Trading

Symbol(s)

  Name of each exchange on which registered
Common Stock, $0.01 par value per share   CON   New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.07Submission of Matters to a Vote of Security Holders.

 

On April 30, 2026, Concentra Group Holdings Parent, Inc. (the “Company”) held its annual meeting of stockholders (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders approved the below proposals. The proposals below are described in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on March 17, 2026. The final voting results for each of the proposals submitted to a vote at the Annual Meeting are as follows:

 

Proposal 1: The Election of Three Class II Directors to the Board of Directors

 

The Company’s stockholders elected the following nominees to serve as Class II directors for a term expiring at the Company’s 2029 annual meeting of stockholders and until each of their successors is duly elected and qualified.

 

Name  Votes For  Votes Against 

Abstentions

  Broker Non-Votes
Vipin Gopal  119,163,036  243,360  6,604  2,527,251
William K. Newton  115,591,819  3,816,147  5,034  2,527,251
Marc R. Watkins, MD  97,602,436  21,766,753  43,811  2,527,251

 

Proposal 2: Non-Binding Advisory Vote on the Compensation of the Company’s Named Executive Officers

 

The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s named executive officers.

 

Votes For  Votes Against 

Abstentions

  Broker Non-Votes
114,180,227  5,143,479  89,294  2,527,251

 

Proposal 3: Ratification of the Appointment of PricewaterhouseCoopers LLP as the Company’s Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2026

 

The Company’s stockholders ratified the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.

 

Votes For  Votes Against  Abstentions  Broker Non-Votes 
121,568,869  360,888  10,494   0 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  CONCENTRA GROUP HOLDINGS PARENT, INC.
   
Date:  April 30, 2026 By: /s/ Timothy Ryan
    Timothy Ryan
    Executive Vice President and Chief Legal Counsel

 

 

 

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Concentra Group Holdings Parent Inc (CON)

Reference

Frequently asked questions

When did Concentra Group Holdings Parent Inc file this 8-K?
Concentra Group Holdings Parent Inc (CON) filed this Current Report (Form 8-K) with the SEC on April 30, 2026. The accession number assigned by EDGAR is 0001104659-26-052886.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Stockholders elected three Class II directors, approved the NEO compensation advisory vote, and ratified PricewaterhouseCoopers LLP as auditor. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Concentra Group Holdings Parent Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Concentra Group Holdings Parent Inc has filed under CIK 2014596, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer